Public Profile

Pfizer (S.A.S.)

Pfizer (S.A.S.), a subsidiary of the global pharmaceutical giant Pfizer Inc., is headquartered in France and operates extensively across Europe and other key regions. Founded in 1849, Pfizer has established itself as a leader in the pharmaceutical industry, focusing on innovative medicines and vaccines that address critical health challenges. The company is renowned for its diverse portfolio, which includes groundbreaking treatments in areas such as oncology, immunology, and rare diseases. Pfizer's commitment to research and development has led to significant milestones, including the rapid development of COVID-19 vaccines, which showcased its agility and expertise in biopharmaceuticals. With a strong market position, Pfizer (S.A.S.) continues to drive advancements in healthcare, making a profound impact on patient outcomes worldwide. Its dedication to quality and innovation sets it apart in a competitive landscape, reinforcing its reputation as a trusted name in the industry.

DitchCarbon Score

How does Pfizer (S.A.S.)'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

51

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Pfizer (S.A.S.)'s score of 51 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.

86%

Let us know if this data was useful to you

Pfizer (S.A.S.)'s reported carbon emissions

Pfizer (S.A.S.), headquartered in France, currently does not have publicly available data regarding its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in the available information. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their carbon footprints. While Pfizer may not have disclosed specific initiatives or targets at this time, it is essential for organisations in this sector to align with global climate commitments and strive for transparency in their environmental impact. As the industry evolves, stakeholders will likely expect Pfizer to establish clear climate commitments and reduction strategies to address carbon emissions effectively.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pfizer (S.A.S.)'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Pfizer (S.A.S.) is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pfizer (S.A.S.) is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers